Close
ACHEMA MIDDLE EAST 2026

Tag: Asia Pacific

WuXi Biologics completes construction of Asia’s largest perfusion biologics manufacturing facility using disposable bioreactors

WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec company, announced today the opening of...

Pfizer Bolsters China Presence With $350 Million Plant

Pfizer Inc. will invest $350 million in eastern China on a plant for biotechnology drugs, bolstering its presence in the world’s second largest pharmaceutical...

Key exhibitors and industry partners show strong support for MEDICAL MANUFACTURING ASIA 2016

3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform            ...

NATCO Pharma Limited receives USFDA tentative approval for Sorafenib Tablets, 200mg

Natco Pharma Limited announced that its marketing partner, Mylan Inc has received a tentative approval for its Abbreviated New Drug Application (ANDA) for Sorafenib...

Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults

Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation in Japan-Originated Drug DiscoveryAstellas Pharma Inc , Daiichi Sankyo Company, Limited...

Popular